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OBJECTIVES: Understanding the changes in chondrogenic gene expression that are involved in the differentiation
of human adipose-derived stem cells to chondrogenic cells is important prior to using this approach for cartilage
repair. The aims of the study were to characterize human adipose-derived stem cells and to examine chondrogenic
gene expression after one, two, and three weeks of induction.
MATERIALS AND METHODS: Human adipose-derived stem cells at passage 4 were evaluated by flow cytometry to
examine the expression of surface markers. These adipose-derived stem cells were tested for adipogenic and
osteogenic differentiation capacity. Ribonucleic acid was extracted from the cells for quantitative polymerase chain
reaction analysis to determine the expression levels of chondrogenic genes after chondrogenic induction.
RESULTS: Human adipose-derived stem cells were strongly positive for the mesenchymal markers CD90, CD73, CD44,
CD9, and histocompatibility antigen and successfully differentiated into adipogenic and osteogenic lineages. The
human adipose-derived stem cells aggregated and formed a dense matrix after chondrogenic induction. The
expression of chondrogenic genes (collagen type II, aggrecan core protein, collagen type XI, COMP, and ELASTIN)
was significantly higher after the first week of induction. However, a significantly elevated expression of collagen
type X was observed after three weeks of chondrogenic induction.
CONCLUSION: Human adipose-derived stem cells retain stem cell characteristics after expansion in culture to
passage 4 and serve as a feasible source of cells for cartilage regeneration. Chondrogenesis in human adipose-
derived stem cells was most prominent after one week of chondrogenic induction.
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INTRODUCTION
The repair of cartilaginous defects remains a significant
clinical challenge, due to the poor spontaneous regeneration
of articular cartilage. This poor regeneration is a result of
an insufficient blood supply and the sparse number of
chondrocytes embedded in the dense extracellular matrix
of articular cartilage. Chondrocyte-based therapy for carti-
lage repair has demonstrated promising clinical outcomes
(1). While this procedure is generally successful, obtaining a
sufficient number of autologous chondrocytes for the
treatment of large cartilage defects is difficult. Moreover,
the procedure requires an invasive protocol for harvesting
the autologous cartilage from a non-weight-bearing site of
the patient’s knee cartilage and creates additional damage to
normal cartilage. Studies have shown that the donor site for
autologous chondrocyte harvesting can experience patholo-
gical changes to the articular cartilage in the joint (2).
Clearly, an alternative source of cells must be used to avoid
the shortcomings of using autologous chondrocytes.
Previous studies have indicated that adult mesenchymal
stem cells can be found in human adipose tissue (3).
Adipose tissue represents a good candidate tissue for
obtaining adult stem cells for regenerative therapy because
it is readily available in a large quantity and can be obtained
through less invasive procedures. Furthermore, the stromal
vascular portion of adipose tissue has been reported to
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contain up to 2% of cells that are able to differentiate into
various cell types, such as osteoblasts, chondrocytes,
adipocytes, and neurons, compared with only 0.002% of
cells with this capability in bone marrow (4). Flow
cytometry analysis has been extensively used to examine
the surface immunophenotype of stem cells isolated from
humans and other species. Previous studies have shown
that human adipose derived stem cells (HADSCs) express a
characteristic adhesion molecule (CD9), mesenchymal stem
cell markers (CD90, CD44, and CD73), and the histocompat-
ibility antigen HLA-ABC. Meanwhile, hematopoietic anti-
gens (CD31, CD34 and CD45), a stem-cell factor (CD117),
and the histocompatibility antigen HLA-DR-DP-DQ have
been reported to be antigens that are absent from the surface
of HADSCs (3). To assess whether HADSCs retain the
immunophenotype of stem cells after expansion in culture,
flow cytometry analysis was performed using the panel of
antibodies described above. Due to the ease of their
collection and their capacity for multipotential differentia-
tion, HADSCs are worthy of consideration as a source of
cells for treatment of cartilage lesions. Stem cells can be
easily expanded in culture for several passages to obtain a
sufficient and homogeneous population of cells before
differentiating into cartilage-generating cells (chondro-
cytes). However, the characteristics and differentiation
capacity of serially passaged HADSCs have not yet been
reported in detail.
In the developing embryo, all bones of the axial skeleton
are formed via cartilage in an intermediate step in the
process of endochondral ossification. During this process,
mesenchymal cells condense and begin to differentiate
along a pathway that ultimately leads to chondrocyte
hypertrophy and mineralized tissue. O’Driscoll et al. have
proposed a model that includes four stages of chondrogen-
esis: (a) commitment of the cells to chondrocytes (0-
48 hours), (b) cell proliferation (1-10 days), (c) differentia-
tion (7-28 days), and (d) matrix production (10-42 days) (5).
Chondrogenesis begins with the aggregation and condensa-
tion of loose mesenchymal stem cells. During this early
event, the condensing mesenchyme expresses various
extracellular matrix (ECM) components, including collagen
type II, aggrecan core protein, cartilage oligomeric matrix
protein (COMP), and the important transcription factor SRY
box 9 (Sox9) (6,7). As the mesenchymal stem cells
differentiate into chondrocytes, the cells begin to produce
ECM materials rich in aggrecan core protein and COMP.
Chondrogenesis by HADSCs may involve a process
similar to that described above. However, to date, the
detailed molecular changes during the chondrogenic induc-
tion of HADSCs have not been examined, although this
information is crucial to determine if a cell-based therapy
protocol is useful for repairing cartilage lesions. To under-
stand the molecular events that are involved in the
differentiation of uncommitted HADSCs to chondrocytes
and the formation of cartilage tissue, we investigated the
sequential expression of chondrogenic genes in HADSCs
during chondrogenic induction after the first, second, and
third week of culture. Knowledge of the rapid changes in
chondrogenic gene expression during chondrogenic induc-
tion in HADSCs will provide a better understanding of the
potential of these stem cells for cartilage repair. Knowledge
of genes that are expressed during chondrogenic induction
in culture is of fundamental importance for the use of stem
cell-based approaches for the treatment of cartilage lesions.
MATERIALS AND METHODS
Human adipose-derived stem cell isolation and
culture
This study was approved by the Universiti Kebangsaan
Malaysia Research and Ethical Committee (Project code FF-
083-2007). Lipoaspirate was obtained from consented
patients (n = 6) after liposuction procedures that were
performed at the Subang Jaya Medical Center in Malaysia.
The specimens were placed in sterile containers and
brought to the Biotechnology Laboratory, Department of
Physiology, Faculty of Medicine, Universiti Kebangsaan,
Malaysia to be processed within 24 hours. Each specimen
was digested with 0.3% collagenase type I (Invitrogen,
Carlsbad, CA, USA) in an orbital incubator at 37 C˚ for four
hours. Next, the cell suspension was centrifuged, and the
cell pellet was washed with phosphate-buffered saline (PBS,
Invitrogen) to remove red blood cells and other impurities.
After a final centrifugation, the cell pellet was suspended in
the control medium Ham’s F12:Dulbecco’s Modified Eagle
Medium (151) supplemented with 10% fetal bovine serum
(FBS), 1% antibiotic and antimycotic, 1% glutamax
(Invitrogen), and 1% Vitamin C (Sigma, St. Louis, MO,
USA). All cultures were maintained in a 5% CO2 incubator
at 37 C˚. The medium was changed every three days. After
reaching 70% confluence, the primary culture (P0) was
trypsinized using 0.05% trypsin-EDTA (Invitrogen) and
passaged at a culture expansion ratio of 154 until passage 4
(P4).
Flow cytometry analysis
Flow cytometry was performed on HADSCs at P4. The
HADSCs were trypsinized using Accutase (Innovative Cell
Technologies, San Diego, CA, USA). The cell suspension
was subsequently centrifuged at 1200 rpm for 10 minutes
and washed with DPBS containing 0.5% Bovine Serum
Album (Sigma). HADSCs were filtered through a 70-mm
nylon membrane, and the number of cells was determined
by hemocytometer. A total of 26105 cells were incubated
with either fluorescein isothiocyanate (FITC)- or phycoery-
thrin (PE)-conjugated antibodies for 30 minutes. The
following CD surface markers were tested: CD9/PE,
CD34/FITC, CD117/PE, CD31/PE, CD44/FITC, CD45/
FITC, CD73/FITC, CD90/FITC, HLA-ABC/FITC and
HLA-DR-DP-DQ/FITC (BD Biosciences, NJ, USA). Ten
thousand events were acquired for each CD surface marker
on a Becton Dickinson FACSCalibur flow cytometer. The
data analysis was performed using CELLQuestPro acquisi-
tion software (BD Bioscience, Franklin Lakes, NJ, USA).
Adipogenic induction of human adipose-derived
stem cells (HADSCs)
Isolated HADSCs were expanded in culture until passage
4 (P4) in an equal volume mix of Ham’s F-12 medium and
Dulbecco’s Modified Eagle Medium supplemented with
10% FBS (control medium). The HADSCs were induced in
an adipogenic induction medium that contained 200 mM
indomethacin, 10 mM insulin, 0.5 mM 3-isobutyl-1-methyl-
xanthine, and 1 mM dexamethasone (Sigma) at a seeding
density of 400 cells/mm2. Media were replaced every three
days, and the cells were maintained in culture for up to
three weeks. After three weeks, the cultures were fixed in
10% formalin, and adipogenic differentiation was deter-
mined by Oil Red O staining.
Sequential chondrogenesis in adipose stem cells
Hamid AA et al.
CLINICS 2012;67(2):99-106
100
Osteogenic induction of human adipose-derived
stem cells (HADSCs)
HADSCs at passage 4 (P4) were induced in an osteogenic
induction medium that contained 100 nM dexamethasone,
10 mM b-glycerophosphate, and 5 mg/ml ascorbate-2-
phosphate (Sigma) at a seeding density of 200 cells/mm2.
The cultures were fed with the osteogenic medium every
three days for up to three weeks. After three weeks, the
cultures were fixed in 10% formalin, and osteogenic
differentiation was determined by Alizarin Red staining.
Chondrogenic induction of human adipose-derived
stem cells (HADSCs)
HADSCs at P4 were cultured in T25 flasks at a cell density
of 9.66104 cells/cm2 in either the chondrogenic induction
medium or the control medium. The chondrogenic induc-
tion medium contained F12:DMEM (1:1) supplemented with
1% FBS, 1% antibiotic and antimycotic, 1% glutamax, 1%
vitamin c, 1% insulin-transferrin-selenium-X (ITS), 50 ng/
mL insulin-like growth factor 1 (IGF-1), 50 mg/mL ascor-
bate-2-phosphate, 100 nM dexamethasone, 40 mg/ml L-
proline, and 5 ng/mL transforming growth factor-b3
(TGF-b3) (Sigma). The morphological features of cultured
cells were monitored every day using an inverted light
microscope (Olympus, Shinjuku-ku, Tokyo, Japan). HADSCs
were harvested after the first, second and third week of
culture for the quantification of sequential chondrogenic
gene expression.
Total RNA isolation and quantitative PCR analysis
Total RNA was extracted from cultured HADSCs after the
first, second, and third week of culture in either the control
medium or the chondrogenic induction medium using TRI
Reagent (Molecular Research Center, Cincinnati, OH) accord-
ing to the manufacturer’s protocol. The HADSCs were
homogenized in TRI reagent and centrifuged at 12,000 x g
for 15 minutes at 4 C˚ to separate the cell debris. Total RNA
was precipitated with 10 mL Polyacryl Carrier (Molecular
Research Center). The total RNA pellet was then washed
with 75% ethanol, dissolved in RNase- and DNase-free water
(Invitrogen) and stored at -80 C˚ until use. Complementary
DNA (cDNA) was synthesized from total RNA using
Superscript III reverse transcriptase (Invitrogen). The reac-
tion mix and protocol were performed following the
manufacturer’s recommendations. The reaction cycle was
10 min at 23 C˚, 60 min at 42 C˚, and 10 min at 94 C˚. To
quantify the expression level of chondrogenic genes after the
first, second, and third week of culture in the chondrogenic
induction medium or the control medium, quantitative
polymerase chain reaction (qPCR) was performed using
cDNA as the template. The genes of interest were collagen
type II, aggrecan core protein, SOX9, COMP, ELASTIN,
collagen type XI, collagen type I (dedifferentiation marker),
and collagen type X (hypertrophy marker). The specific
primer sequences were designed using Primer 3 software
(http://frodo.wi.mit.edu/primer3/) based on the published
GenBank database sequences (Table 1). QPCR was per-
formed in a Bio-Rad iCycler (Bio-Rad, Hercules, CA, USA),
and the data were analyzed using the Bio-Rad iCycler
software. Each qPCR mixture consisted of iQ SYBR
Supermix (Bio-Rad), forward and reverse primers (5 mM of
each) and 1 ml of cDNA template. The following PCR
conditions were used: cycle 1: 95 C˚ for 3 minutes (1X) and
cycle 2: Step 1, 95 C˚ for 10 second and Step 2, 61 C˚ for 30
second (40X). The PCR cycles were followed by a melting-
curve analysis to determine the specificity of the PCR
products. Next, the data were normalized to the expression
of the housekeeping gene GAPDH. The formula for calculat-
ing the relative mRNA expression from the data are as follows:
Relative mRNA expression: 2DDCT
DDC
T = CT housekeeping gene – CT gene of interest
CT = Threshold cycle (relative measure of the concentra-
tion of the target in the PCR reaction)
Statistical Analysis
The data are presented as the mean ¡ the standard error
of the mean (SEM). The gene expressions of collagen type II,
aggrecan core protein, SOX9, COMP, ELASTIN, collagen
type I and collagen type X in the control and chondrogenic
induction groups after induction for one, two and three
weeks were subjected to one-way analysis of variance with a
Tukey post-hoc test and were analyzed using SPSS 15.0 (SPSS
Inc., Chicago, IL). A p-value,0.05 was considered to be
significant.
Table 1 - List of primers used in qPCR for chondrogenic genes (www.ncbi.nlm.nih.gov/nucleotide).
Chondrogenic Gene Gene Bank Accession No. Primer sequences
Human Collagen Type I, Col I NM_000088 F: 59-agg gct cca acg aga tcg aga-39
R: 59-tac agg aag cag aca ggg cca-39
Human Collagen Type II, Col II NM_001844 F: 59-cta tct gga cga agc agc tgg ca-39
R: 59-atg ggt gca atg tca atg atg g-39
Human Collagen Type X, Col X NM_000493 F: 59-gct aag ggt gaa agg ggt tc-39
R: 59-ctc cag gat cac ctt ttg ga-39
Human Collagen Type XI, Col XI NM_080681 F: 59-agc agg ggg tga gac ctg tg -39
R: 59-tgc tcc aga gca ggg gta gg-39
Human Aggrecan Core Protein, ACP NM_001135 F: 59-cac tgt tac cgc cac ttc cc-39
R: 59-acc agc gga agt ccc ctt cg-39
Human Sox9, SOX9 NM_000346 F: 59-gcg gag gaa gtc ggt gaa ga-39
R: 59-ccc tct cgc ttc agg tca gc-39
Cartilage Oligomeric Protein, COMP NM_000095 F: 59-aac tca ggg cag gag gat gt-39
R: 59-tgt cct ttt ggt cgt cgt tc-3
ELASTIN NM_000501 F: 59-ggc ctg gag gca aac ctc tt-39
R: 59-cca cca act cct ggg aca cc-39
GAPDH NM_002046 F: 59-tcc ctg agc tga acg gga ag-39
R: 59-gga gga gtg ggt gtc gct gt-39
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RESULTS
Immunophenotype of HADSCs
HADSCs displayed positive staining for the mesenchymal
surface markers CD90, CD73, CD44, CD9, and HLA-ABC
(Table 2). HADSCs at passage 4 exhibited high levels of
expression of CD90, CD73, CD9 and CD44, which stained
more than 90% of the total cell population. More than 99% of
HADSCs expressed the histocompatibility antigen molecule
HLA-ABC. In contrast, only a small proportion (less than
7%) of HADSCs expressed the hematopoietic markers
CD117, CD34, CD31, CD45, and the histocompatibility
antigen class II HLA-DR-DP-DQ.
Adipogenic and osteogenic differentiation of
HADSCs
After 21 days of culture in the adipogenic induction
medium, lipid droplets had formed in the induced HADSCs
(Figure 1A). Positive Oil Red O staining further confirmed
the formation of lipid droplets in the culture (Figure 1B).
Under osteogenic induction conditions, dark extracellular
matrix material was detected after the induction period
(Figure 1C). Deposition of calcified matrix by the cells was
confirmed by positive staining with Alizarin Red
(Figure 1D).
Morphological features of HADSCs during
chondrogenic induction
After HADSCs were incubated in the chondrogenic
medium for 24 hours, the cells began to move closer to
one another and form cell aggregates. This aggregation
demonstrated that cellular condensation activity started
shortly after chondrogenic induction. The cell aggregates
became larger after a week in culture (Figure 2A). After 14
days in the chondrogenic induction medium, most of the
cells in the culture were involved in aggregate formation,
and empty areas were present in the culture flasks
(Figure 2B). On day 21 of chondrogenic induction, the cell
aggregates became darker in color, which denoted the
formation of dense cell aggregates with increased extra-
cellular matrix production (Figure 2C). HADSCs in the
control medium did not form any cell aggregates during the
three-week culture period. HADSCs in the control medium
continued to grow and form multilayers at the end of the
third week of culture (Figure 2D).
Sequential expression of chondrogenic genes in
HADSCs
The HADSCs cultured in the chondrogenic induction
medium displayed a significantly higher expression of
chondrogenic genes (collagen type II, SOX9, aggrecan core
protein, COMP, collagen type XI, and ELASTIN) than the
control group (Figure 3). Collagen type II mRNA was
expressed only in the chondrogenic induction groups. The
HADSCs expressed significantly higher levels of collagen
type II mRNA after the first week (3.09E-04¡1.89E-04) in
the chondrogenic induction medium compared with both
Table 2 - Immunophenotyping of human adipose-derived
stem cells (HADSCs) at passage 4. Data are presented as
the mean ¡ standard error of the mean (SEM). n=6.
Surface Markers HADSCs at P4
CD90 99.9¡0.1
CD9 91.2¡2.5
CD73 99.8¡0.1
CD44 99.2¡0.2
HLA ABC 99.3¡0.4
CD45 6.2¡0.7
CD117 5.8¡0.8
CD31 1.9¡0.3
CD34 2.4¡0.5
HLA DP, DQ, DR 3.0¡0.3
Figure 1 - Human adipose-derived stem cells (HADSCs) cultured in
adipogenic and osteogenic induction media. (A) Lipid droplet
production in HADSCs after 21 days of adipogenic induction. (B)
Positive Oil Red O staining of the lipid droplets. (C) Calcium
deposition in HADSCs after 21 days of osteogenic induction. (D)
Positive Alizarin Red staining. Magnification 400X.
Figure 2 - Human adipose-derived stem cells (HADSCs) cultured in
a chondrogenic induction medium. (A) After one week of
chondrogenic induction, HADSCs showed early cell condensation
(arrow). (B) Cell aggregates (arrow) became larger in size and
started to store matrices during the second week of chondro-
genic induction. (C) Cell aggregates (arrow) became dense and
dark in color, which denoted increased matrix deposition at the
third week of culture in a chondrogenic induction medium. (D)
HADSCs grown in a control medium did not show any cell
aggregation after three weeks in culture. Magnification 200X.
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Figure 3 - Chondrogenic gene expression in human adipose-derived stem cells cultured for one, two, and three weeks in a
chondrogenic induction medium compared with a control medium. A significantly higher expression of the following chondrogenic
genes was observed in the chondrogenic induction medium compared with the control medium in the first, second, and third weeks of
culture: Collagen type II (a), Collagen type X (b), Collagen type XI (c), Aggrecan core protein (d), SOX9 (e), COMP (f) and ELASTIN (g).
n = 6, p,0.05.
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the second week (2.72E-09¡2.72E-09) and the third week
(1.28E-07¡1.28E-07) of culture. Aggrecan core protein
(ACP) was also expressed at the highest level after the
first week of chondrogenic induction. The induced cells
displayed a fourfold higher ACP expression after the first
week (1.46E-03¡0.56E-03) compared with the same culture
duration of the control group. Subsequent culturing of the
cells in the chondrogenic medium caused a reduction in
ACP expression to 2.50E-04¡1.46E-04 at the second week
and 3.13E-04¡1.02E-04 at the third week of culture.
Similarly, COMP expression was significantly higher in
the HADSCs after the first week of culture in the
chondrogenic induction medium compared with the other
groups. The HADSCs expressed 2.5-fold higher COMP
mRNA expression after the first week of culture compared
with the control group, 10-fold higher COMP expression
after the second week and 8-fold higher COMP expression
after the third week. Both ELASTIN and collagen type XI
were also expressed at the highest level after the first week
of chondrogenic induction compared with the other
groups. However, SOX9 expression reached the highest
level at the third week of culture in the chondrogenic
induction medium. SOX9 expression at the third week was
significantly higher than at the first and second week in the
chondrogenic induction group and all of the control
groups.
In contrast, collagen type I (a dedifferentiation marker)
was expressed at significantly higher levels at the first week
of HADSC culture in the control medium. HADSCs in the
chondrogenic induction medium expressed a much lower
level of collagen type I expression; this expression was
maintained at a steady state throughout the three weeks of
culture compared with the control groups.
Finally, HADSCs expressed significantly higher levels of
collagen type X (a hypertrophy marker) mRNA expression
at the third week of culture in the chondrogenic induction
medium compared with the other groups. HADSCs
expressed 8.5-fold higher collagen type X mRNA expression
at the third week of culture compared with cells cultured in
the control medium for the same culture period and 4-fold
higher collagen type X expression compared with the first
and second week of culture of HADSCs in the chondrogenic
medium.
DISCUSSION
The characterization of any source of stem cells after
expansion in culture is crucial for determining if the
cultured cells retain the stemness criteria required for cell-
based therapy and testing purposes. HADSCs were cultured
to passage 4 to obtain sufficient cells for analysis in this
study. Standard characterization methods assess the expres-
sion of mesenchymal markers and the multilineage differ-
entiation capacity of the stem cells. Based on flow cytometry
analyses, HADSCs at P4 showed high expression of the
mesenchymal adhesion molecule CD9 and surface marker
CD44. CD9 plays an important role in cell adhesion during
in vitro culture and acts as a useful marker for evaluating the
characteristics and potential of stem cells (8). HADSCs at P4
expressed high levels of CD44, a receptor for hyaluronic
acid that aids HADSC migration into the injured tissue
during the tissue regeneration process (9). Another specific
surface marker for mesenchymal stem cells is CD73, which
is not expressed in hematopoietic stem cells, osteoblasts, or
osteocytes (10). High expression of CD44 and CD73 in
HADSCs has also been reported in previous studies (11-13).
A small population of HADSCs at P4 expressed the
hematopoietic surface markers CD34, CD45, and CD31.
This small percentage of cells is negligible and does not
interfere with the multipotent ability of HADSCs (12,14).
The culture of HADSCs at P4 was also free of fibroblasts,
which are positive for CD34 (15). The low expression of
molecular MHC class II (HLA-DP-PQ-DR) suggests the
potential of HADSCs for allogenic cell transplantation, due
to a lower risk of rejection (16). CD117 is known to play a
role in the survival, proliferation and migration of bone
marrow stem cells, but it is poorly expressed in HADSCs, as
shown by previous work (3). Thus, our results show that
after expansion in culture, HADSCs retained stem cell
surface marker expression and were unlikely to be
contaminated with hematopoietic cells and other differen-
tiated cells (13). Second, after expansion in culture to
passage 4, the HADSCs demonstrated the capacity for
multilineage differentiation into adipogenic and osteogenic
cells. These results further support the data suggesting that
the HADSCs expanded in culture in this study retained
stem cell characteristics and could be used for cartilage
regeneration.
The development of cartilage tissue involves the process
of mesenchymal stem cell condensation, aggregation, and
differentiation into chondroblasts followed by cell matura-
tion, hypertrophy, calcification, and ultimately cell death
(17). Cartilage formation during embryonic development
starts with the formation of aggregates of mesenchymal
progenitor cells and condensation, which play an important
role in creating the microenvironment for chondrogenesis
(18). Although the successful chondrogenic differentiation
of human mesenchymal stem cells has been reported, the
sequential mRNA expression profile has not been examined
during the induction stage. In this study, after 24 hours of
culture in a chondrogenic induction medium, HADSCs
began to attract one another and form cell aggregates. This
aggregation denoted the condensation process of the early
stage of chondrogenesis. Following cell condensation,
HADSCs began to express significantly higher levels of
collagen type II, aggrecan core protein, COMP, ELASTIN,
and collagen type XI in the first week of induction. In
addition, the expression of ELASTIN mRNA in this study
showed the feasibility of using differentiated HADSCs for
elastic cartilage regeneration, such as in ear (19) and trachea
reconstruction (20). The transcription factor SOX9 is an early
marker that is expressed during cell condensation to
regulate collagen type II and cartilage-specific matrix
synthesis (21). Our results showed that continued culture
in the chondrogenic induction medium further increased
SOX9 expression in HADSCs (compared with the control
group), and SOX9 expression reached its highest level at the
third week of culture, which could further promote the
production of cartilage matrix. Other studies have also
shown successful chondrogenic induction upon transfection
of SOX9 into human bone-marrow stem cells for cartilage
formation (22).
Our study showed that the expression of most of the
chondrogenic genes in induced HADSCs (collagen type II,
aggrecan core protein, COMP, ELASTIN, and collagen type
XI) was reduced at the second and third week of culture.
This reduction may have been due to the extracellular
matrix mRNA expression returning to the baseline level
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after the condensation and aggregation process during the
first week of induction. Thus, continuous culture of the cells
in the chondrogenic induction medium did not promote
further extracellular matrix production to increase the size
of cell aggregates. These results suggest that chondrogenic
induction of stem cells for one week may be sufficient
for cartilage regeneration. In addition, chondrogenesis is
hypothesized to be regulated by the sequential exposure of
the chondrogenic induction factors in a specific timeframe.
Therefore, further studies should evaluate the sequential
combination of various growth factors to achieve more
complete chondrogenesis in HADSCs.
The high expression of a hypertrophy marker, collagen
type X, at the third week of chondrogenic induction
suggests that the continuous induction of HADSCs could
lead the cells toward a hypertrophic state and increased
bone matrix synthesis. Several factors have been shown to
be related to chondrocyte hypertrophy in vitro, such as
the use of the TGF family and dexamethasone (23-24).
Therefore, the removal of these two factors in the later
period of induction could decrease the hypertrophy process
in HADSCs.
Serum-derived growth factors may also limit the con-
tinuation of chondrogenesis in stem cells. The ideal
chondrogenic induction medium should be totally serum-
free such that interference from the serum-derived growth
factors can be avoided. However, cells also need proteins
such as fibronectin for adherence and other factors from
serum to reduce apoptosis (25). Our previous report has
shown that supplementation with ITS, IGF-1, bFGF, and
TGF-ß2 in the culture medium can promote human
chondrocytes to maintain differentiated phenotypes and
increased proliferation (26). Furthermore, the formation of
good trachea cartilage also requires serum supplementation
(20). Human serum from either an autologous or allogenic
source is also known to promote articular chondrocyte
growth (27). In addition, supplementation with a combina-
tion of human serum and bFGF can enhance human nasal
septum chondrocyte proliferation and can promote cartilage
regeneration (28). Perhaps a serum-free chondrogenic
induction medium should also include factors used in
chondrocyte culture to reduce cell death and increase
chondrogenesis.
HADSCs expanded in culture to passage 4 retained
stem cell characteristics and served as a feasible source of
cells for cartilage regeneration. Chondrogenesis in
HADSCs was most prominent after the first week of
chondrogenic induction, but a longer induction period can
provoke hypertrophy. Thus, the findings of this study
suggest that future studies should investigate the use of
HADSCs induced for one week in chondrogenic condi-
tions for cartilage regeneration. This approach could be
used in the near future to reduce the time and costs
associated with preparing stem cells for the treatment of
cartilage lesions.
ACKNOWLEDGMENTS
This study was made possible by a grant from the Ministry of Science,
Technology and Innovation of Malaysia: eScienceFund 02-01-02-SF0290.
AUTHOR CONTRIBUTIONS
Hamid AA was the first author, responsible for performing the experiment,
analyzing the data and drafting the manuscript. Idrus RBH and Saim AB
were co-supervisors of the project, involved in data analysis and manuscript
drafting. Sathappan S was co-researcher in the project, provided specimens
and was involved in data analysis. Chua KH was the corresponding author,
principal investigator, responsible for the planning of the experiment,
supervision of the progress of the experiment, data analysis, and final
approval of the manuscript.
REFERENCES
1. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L.
Treatment of deep cartilage defects in the knee with autologous
chondrocyte transplantation. N Engl J Med. 1994;331:889-95.
2. Lee CR, Grodzinsky AJ, Hsu HP, Martin SD, Spector M. Effects of
harvest and selected cartilage repair procedures on the physical and
biochemical properties of articular cartilage in the canine knee. J Orthop
Res. 2000;18:790-9, http://dx.doi.org/10.1002/jor.1100180517.
3. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. 2002.
Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell.
2002;13:4279-95, http://dx.doi.org/10.1091/mbc.E02-02-0105.
4. Strem BM, Hedrick MH. The growing importance of fat in regenerative
medicine. Trends Biotechnol. 2005;23:64-6, http://dx.doi.org/10.1016/
j.tibtech.2004.12.003.
5. O’Driscoll SW, Fitzsimmons JS. The role of periosteum in cartilage
repair. Clin Orthop Relat Res. 2001;391:S190-207, http://dx.doi.org/
10.1097/00003086-200110001-00019.
6. Ng LJ, Tam PP, Cheah KS. Preferential expression of alternatively spliced
mRNAs encoding type II procollagen with a cysteine-rich amino-
propeptide in differentiating cartilage and nonchondrogenic tissues
during early mouse development. Dev Biol. 1993;159:403-17, http://
dx.doi.org/10.1006/dbio.1993.1251.
7. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B.
The transcription factor Sox9 has essential roles in successive steps of the
chondrocyte differentiation pathway and is required for expression of
Sox5 and Sox6. Genes Dev. 2002;16:2813-28, http://dx.doi.org/10.1101/
gad.1017802.
8. Kim YJ, Yu JM, Joo HJ, Kim HK, Cho HH, Bae YC, et al. Role of CD9 in
proliferation and proangiogenic action of human adipose-derived
mesenchymal stem cells. Pflugers Arch. 2007;455:283-96, http://
dx.doi.org/10.1007/s00424-007-0285-4.
9. Zhu H, Mitsuhashi N, Klein A, Barsky LW, Weinberg K, Barr ML, et al.
The role of the hyaluronan receptor CD44 in mesenchymal stem cell
migration in the extracellular matrix. Stem Cells. 2006;24:928-35, http://
dx.doi.org/10.1634/stemcells.2005-0186.
10. Haynesworth SE, Baber MA, Caplan AI. Cell surface antigens on human
marrow-derived mesenchymal cells are detected by monoclonal anti-
bodies. Bone. 1992;13:69-80, http://dx.doi.org/10.1016/8756-3282(92)
90363-2.
11. Mitchell JB, McIntosh K, Zvonic S, Garrett S, Floyd ZE, Kloster A, et al.
Immunophenotype of human adipose-derived cells: temporal changes in
stromal-associated and stem cell-associated markers. Stem Cells.
2006;24:376-85, http://dx.doi.org/10.1634/stemcells.2005-0234.
12. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC. Cell surface and
transcriptional characterization of human adipose-derived adherent
stromal (hADAS) cells. Stem Cells. 2005;23:412-23, http://dx.doi.org/
10.1634/stemcells.2004-0021.
13. Kolf CM, Cho E, Tuan RS. Mesenchymal stromal cells. Biology of adult
mesenchymal stem cells: regulation of niche, self-renewal and differ-
entiation. Arthritis Res Ther. 2007;9:204, http://dx.doi.org/10.1186/
ar2116.
14. Charrie`re G, Cousin B, Arnaud E, Andre´ M, Bacou F, Penicaud L, et al.
Preadipocyte conversion to macrophage: Evidence of plasticity. J Biol
Chem. 2003;278:9850-5, http://dx.doi.org/10.1074/jbc.M210811200.
15. D’Andrea F, De Francesco F, Ferraro GA, Desiderio V, Tirino V, De Rosa A,
et al. Large-scale production of human adipose tissue from stem cells: a
new tool for regenerative medicine and tissue banking. Tissue Eng.
Part C Methods. 2008;14:233-42, http://dx.doi.org/10.1089/
ten.tec.2008.0108.
16. McIntosh K, Zvonic S, Garrett S, Mitchell JB, Floyd ZE, Hammill L, et al.
The immunogenicity of human adipose-derived cells: temporal changes
in vitro. Stem Cells. 2006;24:1246-53, http://dx.doi.org/10.1634/
stemcells.2005-0235.
17. Izzo MW, Pucci B, Tuan RS, Hall DJ. Gene expression profiling following
BMP-2 induction of mesenchymal chondrogenesis in vitro. Osteoarthritis
Cartilage. 2002;10:23-33, http://dx.doi.org/10.1053/joca.2001.0478.
18. Stott NS, Jiang TX, Chuong CM. Successive formative stages of
precartilaginous mesenchymal condensations in vitro: modulation of
cell adhesion by Wnt-7A and BMP-2. J Cell Physiol. 1999;180:314-24,
http://dx.doi.org/10.1002/(SICI)1097-4652(199909)180:3,314::AID-
JCP2.3.0.CO;2-Y.
19. Ruszymah BH, Lokman BS, Asma A, Munirah S, Chua K, Mazlyzam AL,
Isa MR, Fuzina NH, Aminuddin BS. Pediatric auricular chondrocytes
gene expression analysis in monolayer culture and engineered elastic
CLINICS 2012;67(2):99-106 Sequential chondrogenesis in adipose stem cells
Hamid AA et al.
105
cartilage. Int J Pediatr Otorhinolaryngol. 2007;71:1225-34, http://
dx.doi.org/10.1016/j.ijporl.2007.04.014.
20. Ruszymah BH, Chua K, Latif MA, Hussein FN, Saim AB. Formation of in
vivo tissue engineered human hyaline cartilage in the shape of a trachea
with internal support. Int J Pediatr Otorhinolaryngol. 2005;69:1489-95,
http://dx.doi.org/10.1016/j.ijporl.2005.04.026.
21. Ng LJ, Wheatley S, Muscat GE, Conway-Campbell J, Bowles J, Wright E,
et al. SOX9 binds DNA, activates transcription and coexpresses with type
II collagen during chondrogenesis in the mouse. Dev Biol. 1997;183:108-
21, http://dx.doi.org/10.1006/dbio.1996.8487.
22. Babister JC, Tare RS, Green DW, Inglis S, Mann S, Oreffo RO. Genetic
manipulation of human mesenchymal progenitors to promote chondro-
genesis using ‘‘bead-in-bead’’ polysaccharide capsules. Biomaterials.
2008;29:58-65.
23. Cancedda R, Castagnola P, Cancedda FD, Dozin B, Quarto R.
Developmental control of chondrogenesis and osteogenesis. Int J Dev
Biol. 2000;44:707-14.
24. Leboy PS, Sullivan TA, Nooreyazdan M, Venezian RA. Rapid chon-
drocyte maturation by serum-free culture with BMP-2 and ascorbic acid.
J Cell Biochem. 1997;66:394-03.
25. Wong M, Tuan RS. Nuserum, a synthetic serum replacement, supports
chondrogenesis of embryonic chick limb bud mesenchymal cells in
micromass culture. In Vitro Cell Dev Biol Anim. 1993;29A:917-22, http://
dx.doi.org/10.1007/BF02634229.
26. Chua KH, Aminuddin BS, Fuzina NH, Ruszymah BHI. Insulin-
Transferrin-Selenium prevent human chondrocyte dedifferentiation
and promote the formation of high quality tissue engineered human
hyaline cartilage. Eur Cell Mater. 2005;9:58-67.
27. Munirah S, Ruszymah BH, Samsudin OC, Badrul AH, Azmi B, Aminuddin
BS. Autologous versus pooled human serum for articular chondrocyte
growth. J Orthop Surg. (Hong Kong) 2008;16:220-9.
28. Chua KH, Aminuddin BS, Fuzina NH, Ruszymah BHI. Basic fibroblast
growth factor with human serum supplementation: enhancement of
human chondrocyte proliferation and promotion of cartilage regenera-
tion. Singapore Med J. 2007;48:324-32.
Sequential chondrogenesis in adipose stem cells
Hamid AA et al.
CLINICS 2012;67(2):99-106
106
